How long can you live with conservative treatment of mid- to late-stage rectal cancer?

How long can you live with conservative treatment of mid-to-late stage rectal cancer?

It is uncertain how long patients with mid- to late-stage rectal cancer can survive with conservative treatment because patients' constitutions and responses to medications vary.

Rectal cancer is a malignant tumor that originates in the rectal mucosal epithelium. The causes of its formation are related to bad eating habits, genetic factors, etc. Rectal cancer generally has no obvious discomfort symptoms in the early stage, so it is easy to be ignored. As the tumor volume increases, it will develop to the middle and late stages. At this time, the tumor will cause compression to the surrounding tissues and reduce the volume of the intestinal cavity, which will manifest as swelling of the anus before defecation, changes in the nature of defecation, etc. If the patient with middle and late stage rectal cancer has a strong personal constitution, the tumor has not metastasized, and maintains a scientific and reasonable lifestyle and eating habits, it will have little impact on the patient's survival time; if the patient with middle and late stage rectal cancer has a poor personal constitution, the tumor has metastasized a lot, and life and diet care are not strengthened, it may have a greater impact on the patient's survival time, but it is uncertain how long he can live.

Patients with rectal cancer can use targeted drugs such as bevacizumab injection, cetuximab injection, and furiquintinib capsules for treatment under the guidance of a doctor, and use them strictly according to the doctor's advice.